4//SEC Filing
Chiprin Jeff 4
Accession 0001415889-24-029273
CIK 0001325618other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:00 PM ET
Size
8.2 KB
Accession
0001415889-24-029273
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
Chiprin Jeff
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2024-12-11+2,990→ 2,990 total→ Common Stock (2,990 underlying) - Award
Performance-based Restricted Stock Units
2024-12-11+2,989→ 2,989 total→ Common Stock (2,989 underlying)
Footnotes (3)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
- [F3]The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2023 Equity Incentive Plan. PRSUs convert into common stock on a one-for-one basis. The PRSUs vest over a three-year performance period from December 12, 2024 through December 11, 2027 on the Company's total stockholder return compared to the NASDAQ US Small Cap Medical Equipment index.
Documents
Issuer
IRADIMED CORP
CIK 0001325618
Entity typeother
Related Parties
1- filerCIK 0002047489
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:00 PM ET
- Size
- 8.2 KB